AMERICAN SOCIETY OF CLINICAL ONCOLOGY for AMERICAN SOCIETY OF CLINICAL ONCOLOGY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHELAGH FOSTER | — |
| KRISTIN MCDONALD | — |
| AMANDA SCHWARTZ | — |
Media (information/publishing) MIA
FASTR Act (Free Access to Science and Technology Research Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHELAGH FOSTER | — |
| KRISTIN MCDONALD | — |
| AMANDA SCHWARTZ | — |
Health Issues HCR
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) FDA User Fee Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHELAGH FOSTER | — |
| KRISTIN MCDONALD New | — |
| AMANDA SCHWARTZ | — |
Budget/Appropriations BUD
FY 2017 and FY 2018 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA, and the Cancer Moonshot Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHELAGH FOSTER | — |
| KRISTIN MCDONALD | — |
| AMANDA SCHWARTZ | — |
Tobacco TOB
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHELAGH FOSTER | — |
| KRISTIN MCDONALD | — |
| AMANDA SCHWARTZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.